Company

Neuropathix, Inc.

Pharmaceutical Manufacturing Doylestown, Pennsylvania, United States 3 employees

Employees: 3
Contacts: 1
Emails: 1
Phones: 1

www.neuropathix.com LinkedIn

Neuropathix, Inc. Overview

Headquarters: Doylestown, Pennsylvania, United States
Website: www.neuropathix.com
Industry: Pharmaceutical Manufacturing
Employees: 3
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

jobs

About Neuropathix, Inc.

Neuropathix, Inc. is a pioneering biopharmaceutical company advancing globally patented, synthetic cannabinoid-inspired therapeutics for the treatment of neurodegenerative and neuropathic diseases. Headquartered at the Pennsylvania Biotechnology Center with its wholly owned subsidiary Kannalife Sciences, Inc., it’s lead drug candidate, KLS-13019, targets key drivers of neuroinflammation and mitochondrial dysfunction, including mNCX-1, GPR55, and the NLRP3 inflammasome. The company’s innovation has been recognized through substantial non-dilutive funding, including a $1.5 million grant from The Michael J. Fox Foundation for Parkinson’s Research and $3.3 million from the NIH HEAL Initiative to support IND-enabling studies to advance KLS-13019 toward clinical trials.

Neuropathix, Inc. Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

Neuropathix, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Thoma Kikis	^	New York City Metropolitan Area, United States	Email Phone
Tage Honoré	President Aestus Partners Llc		View
Dean Petkanas	Chief Executive Officer at Kannalife	Doylestown, Pennsylvania, United States	View